BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 17724707)

  • 1. Prognostic significance of synaptophysin in stage I of squamous carcinoma and adenocarcinoma of the lung.
    González-Aragoneses F; Moreno-Mata N; Cebollero-Presmanes M; García-Yuste M; Cañizares-Carretero MA; Molins-López-Rodó L; Quevedo-Losada S; Torres-Lanzas J; Alvarez-Fernández E;
    Cancer; 2007 Oct; 110(8):1776-81. PubMed ID: 17724707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD98 expression is associated with poor prognosis in resected non-small-cell lung cancer with lymph node metastases.
    Kaira K; Oriuchi N; Imai H; Shimizu K; Yanagitani N; Sunaga N; Hisada T; Kawashima O; Kamide Y; Ishizuka T; Kanai Y; Nakajima T; Mori M
    Ann Surg Oncol; 2009 Dec; 16(12):3473-81. PubMed ID: 19777189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic implications of neuroendocrine differentiation and hormone production in patients with Stage I nonsmall cell lung carcinoma.
    Pelosi G; Pasini F; Sonzogni A; Maffini F; Maisonneuve P; Iannucci A; Terzi A; De Manzoni G; Bresaola E; Viale G
    Cancer; 2003 May; 97(10):2487-97. PubMed ID: 12733148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polymorphisms in the FAS and FASL genes and survival of early stage non-small cell lung cancer.
    Park JY; Lee WK; Jung DK; Choi JE; Park TI; Lee EB; Cho S; Park JY; Cha SI; Kim CH; Kam S; Jung TH; Jheon S
    Clin Cancer Res; 2009 Mar; 15(5):1794-800. PubMed ID: 19240174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of MDA-7/IL-24 and its clinical significance in resected non-small cell lung cancer.
    Ishikawa S; Nakagawa T; Miyahara R; Kawano Y; Takenaka K; Yanagihara K; Otake Y; Katakura H; Wada H; Tanaka F
    Clin Cancer Res; 2005 Feb; 11(3):1198-202. PubMed ID: 15709189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical significance of IGF1R expression in non-small-cell lung cancer.
    Nakagawa M; Uramoto H; Oka S; Chikaishi Y; Iwanami T; Shimokawa H; So T; Hanagiri T; Tanaka F
    Clin Lung Cancer; 2012 Mar; 13(2):136-42. PubMed ID: 22133293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Maspin expression and its clinical significance in non-small cell lung cancer.
    Nakagawa M; Katakura H; Adachi M; Takenaka K; Yanagihara K; Otake Y; Wada H; Tanaka F
    Ann Surg Oncol; 2006 Nov; 13(11):1517-23. PubMed ID: 17009165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic value of intraoperative pleural lavage cytology for lung cancer without carcinomatous pleuritis: importance in patients with early stage disease during long-term follow-up.
    Higashiyama M; Oda K; Okami J; Maeda J; Kodama K; Takenaka A; Nakayama T; Yoneda G
    Eur J Cardiothorac Surg; 2009 Feb; 35(2):337-42. PubMed ID: 19041255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prognostic significance of neuroendocrine markers and carcinoembryonic antigen in patients with resected stage I and II non-small cell lung cancer.
    Graziano SL; Tatum AH; Newman NB; Oler A; Kohman LJ; Veit LJ; Gamble GP; Coleman MJ; Barmada S; O'Lear S
    Cancer Res; 1994 Jun; 54(11):2908-13. PubMed ID: 8187076
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic impact of large cell neuroendocrine histology in patients with pathologic stage Ia pulmonary non-small cell carcinoma.
    Iyoda A; Hiroshima K; Moriya Y; Sekine Y; Shibuya K; Iizasa T; Nakatani Y; Fujisawa T
    J Thorac Cardiovasc Surg; 2006 Aug; 132(2):312-5. PubMed ID: 16872955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of a low risk subgroup of stage IB lung adenocarcinoma patients.
    Mizuno T; Ishii G; Nagai K; Yoshida J; Nishimura M; Mochizuki T; Kawai O; Hasebe T; Ochiai A
    Lung Cancer; 2008 Dec; 62(3):302-8. PubMed ID: 18486987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distribution according to histologic type and outcome by gender and age group in Taiwanese patients with lung carcinoma.
    Chen KY; Chang CH; Yu CJ; Kuo SH; Yang PC
    Cancer; 2005 Jun; 103(12):2566-74. PubMed ID: 15852359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estrogen-receptor-related protein p29 in primary nonsmall cell lung carcinoma: pathologic and prognostic correlations.
    Vargas SO; Leslie KO; Vacek PM; Socinski MA; Weaver DL
    Cancer; 1998 Apr; 82(8):1495-500. PubMed ID: 9554526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunocytochemical detection of occult tumor cells in the bone marrow: prognostic impact on early stages of lung cancer.
    Nosotti M; Tosi D; Palleschi A; Rosso L; Mendogni P; Santambrogio L
    Eur Surg Res; 2008; 41(3):267-71. PubMed ID: 18594145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simultaneous expression of Cathepsins B and K in pulmonary adenocarcinomas and squamous cell carcinomas predicts poor recurrence-free and overall survival.
    Cordes C; Bartling B; Simm A; Afar D; Lautenschläger C; Hansen G; Silber RE; Burdach S; Hofmann HS
    Lung Cancer; 2009 Apr; 64(1):79-85. PubMed ID: 18760860
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A 25-signal proteomic signature and outcome for patients with resected non-small-cell lung cancer.
    Yanagisawa K; Tomida S; Shimada Y; Yatabe Y; Mitsudomi T; Takahashi T
    J Natl Cancer Inst; 2007 Jun; 99(11):858-67. PubMed ID: 17551146
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sex-associated differences in non-small cell lung cancer in the new era: is gender an independent prognostic factor?
    Hsu LH; Chu NM; Liu CC; Tsai SY; You DL; Ko JS; Lu MC; Feng AC
    Lung Cancer; 2009 Nov; 66(2):262-7. PubMed ID: 19299032
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Postoperative recurrence of the patients with the stage I, II non small cell lung cancer].
    Iwamoto I; Shibata K; Yoshioka M; Matsuzaki Y; Yamamoto T; Edagawa M; Kubota I; Tsuneyoshi A; Koga Y
    Kyobu Geka; 1990 Apr; 43(4):267-70. PubMed ID: 2161967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low socioeconomic status is a poor prognostic factor for survival in stage I nonsmall cell lung cancer and is independent of surgical treatment, race, and marital status.
    Ou SH; Zell JA; Ziogas A; Anton-Culver H
    Cancer; 2008 May; 112(9):2011-20. PubMed ID: 18361399
    [TBL] [Abstract][Full Text] [Related]  

  • 20. L-type amino acid transporter 1 expression is a prognostic marker in patients with surgically resected stage I non-small cell lung cancer.
    Imai H; Kaira K; Oriuchi N; Yanagitani N; Sunaga N; Ishizuka T; Kanai Y; Endou H; Nakajima T; Mori M
    Histopathology; 2009 Jun; 54(7):804-13. PubMed ID: 19635099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.